Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Neuroinflammation and Neurodegeneration Mechanisms.
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial
Depressive Symptoms and Amyloid Pathology
Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease
Machine learning in Alzheimer’s disease genetics
Application of IVDr NMR spectroscopy to stratify Parkinson’s disease with absolute quantitation of blood serum metabolites and lipoproteins
Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation
Cognitive reserve against Alzheimer’s pathology is linked to brain activity during memory formation
Perivascular space enlargement accelerates in ageing and Alzheimer’s disease pathology: evidence from a three-year longitudinal multicentre study
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)
Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients
Unveiling the power of high-dimensional cytometry data with cyCONDOR
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects
Locus coeruleus signal intensity and emotion regulation in agitation in Alzheimer’s disease
Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
Short communication: Lifetime musical activity and resting-state functional connectivity in cognitive networks
X‐chromosome-wide association study for Alzheimer’s disease
The Cerebrospinal Fluid Free-Glycans Hex1 and HexNAc1Hex1Neu5Ac1 as Potential Biomarkers of Alzheimer’s Disease
Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age—Results from the Multicentre Observational DELCODE Study
Reduced expression of fMRI subsequent memory effects with increasing severity across the Alzheimer’s disease risk spectrum
Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer’s disease spectrum
A generalizable data‐driven model of atrophy heterogeneity and progression in a memory clinic setting
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypes